BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio

NEXT STORY
BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update
PREV STORY
OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

A Post-hoc Analysis of Phase 3 Study Demonstrates Baseline Factors Associated with Visual Acuity and Anatomical Outcomes of Samsung Bioepis’ BYOOVIZ™ (Ranibizumab) in nAMD at the EURETINA 2021

author_avatar
NASDAQ Market News

Study Published in The New England Journal of Medicine Demonstrates Patients Experience Fewer Disruptions to Dialysis Therapy When Treated with Medtronic Drug-Coated Balloon

author_avatar
NASDAQ Market News

BeiGene and Medison Pharma Announce Exclusive Distribution Agreement and Acceptance of New Drug Application for BTK Inhibitor BRUKINSA™ (zanubrutinib) in Israel

author_avatar
NASDAQ Market News